ANIMATION

Curosurf Intratracheal Suspension

Share this animation:

Neonatal respiratory distress syndrome (RDS) is caused by inadequate surfactant production within the underdeveloped lung, which may result in atelectesis. Curosurf (poractant alfa) is an intratracheal surfactant suspension indicated for the rescue treatment of premature infants suffering from RDS.

Share It:
Contact XVIVO

Client


Cornerstone Therapeutics

XVIVO’s professional team met the many challenges posed by a pre-launch product and rendered visually compelling, high quality animations.

Vice President, Management Supervisor, Ogilvy Healthworld Medical Education
Share this animation: